glp-1 agonists ozempic Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care Is GLP-1 the Same as
Description
Nabeno M, Akahoshi F, Kishida H, et al
Lancet Neurol 14(3):329340 Biessels GJ, Verhagen C, Janssen J et al (2019) Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial
doi: 10.1056/NEJMoa2403347 [DOI] [PubMed] [Google Scholar] 257
In 2009, a second GLP-1 RA was approved liraglutide, which has to be injected once daily
The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events in 17,604 adults with preexisting cardiovascular disease, overweight or obesity, without diabetes [1] [2]
